Last year, 25 billion rubles (-26% per year) was completed with income. The company’s profit fell 41% and was 4.4 billion rubles. About it Is writing The telegram channel “without a prescription” with reference to the data of rusprofile against the data of the verification service.
Post says Otisifarm ranks 42nd in the ranking of the best income companies in the wholesale industry in non -food consumer products. There was no information about the company’s participation in the government in 2024.
Despite a sharp decrease in financial indicators, Otysfarm entered the Sostav internet portal rating into thirty big Russian advertisers. Throughout the year, Arbidol manufacturer ranked 19th to 17th in the list of the largest advertisers. In 2023, 3.9 million rubles were spent for advertising and in 2024, 6.1 million rubles.
Otisifarm is one of the largest Russian pharmaceutical companies specializing in the production and promotion of -Counter drugs and biologically active additives. The company was founded in 2013 as a result of the reorganization of Farmstandart. In addition to Arbidol, the company produces antiviral “amiksin”, sedatives and anxialics (“Afobasol”) and other drugs. The company’s factories operate in Kursk, Ufa, Kaliningrad. In 2023, a new facility was opened in Kaliningrad region that can produce up to 320 million drug packages annually.
Previously named Two products for the prevention of coronavirus.
What are you thinking?
Source: Gazeta
Ben Stock is a business analyst and writer for “Social Bites”. He offers insightful articles on the latest business news and developments, providing readers with a comprehensive understanding of the business world.